View More Recent Stories

Aug 7, 2024 04:05PM Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
Jul 17, 2024 09:00AM Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
View More Recent Stories